Evidence map›Paper›PMID 31672061›Full record

ArticleHuman gene therapy2019

A Common Outer Retinal Change in Retinal Degeneration by Optical Coherence Tomography Can Be Used to Assess Outcomes of Gene Therapy.

Myung Kuk Joe, Wenbo Li, Suja Hiriyanna, Wenhan Yu, Shreya A Shah, Mones Abu-Asab, Haohua Qian, Zhijian Wu

Abstract read
In one paragraph

Article in Human gene therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Myung Kuk JoeOcular Gene Therapy Core, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
Wenbo LiOcular Gene Therapy Core, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
Suja HiriyannaOcular Gene Therapy Core, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
Wenhan YuOcular Gene Therapy Core, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
Shreya A ShahOcular Gene Therapy Core, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
Mones Abu-AsabHistopathology Core, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
Haohua QianVisual Function Core, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
Zhijian WuOcular Gene Therapy Core, National Eye Institute, National Institutes of Health, Bethesda, Maryland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Identifying early disease hallmarks in animal models with slow disease progression may expedite disease detection and assessment of treatment outcomes. Using optical coherence tomography, a widely applied noninvasive method for monitoring retinal structure changes, we analyzed retinal optical sections from six mouse lines with retinal degeneration caused by mutations in different disease-causing genes. While images from wild-type mice revealed four well-separated hyper-reflective bands in the outer retina (designated as outer retina reflective bands, ORRBs) at all ages, the second band (ORRB2) and the third band (ORRB3) were merged in retinas of five mutant mouse lines at early ages, suggesting the pathological nature of this alteration. This ORRB change appeared to be degenerating photoreceptor related, and occurred before obvious morphological changes that can be identified on both hematoxylin and eosin-stained sections and electron microscopic sections. Importantly, the merging of ORRB2 and ORRB3 was reversed by treatment with adeno-associated viral vector-mediated gene replacement therapies, and this restoration occurred much earlier than measurable functional or structural improvement. Our data suggest that the ORRB change could be a common hallmark of early retinal degeneration and its restoration could be used for rapid and noninvasive assessment of therapeutic effects following gene therapy or other treatment interventions.

Indexed as

Genetic TherapyTomography, Optical CoherenceAnimalsDisease Models, AnimalHumansMiceRetinaRetinal DegenerationAAV vectorsgene therapyOCTretinal degeneration

Identifiers

PMID31672061
PMCPMC6919282

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.